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Objective: To evaluate the anti-inﬂammatory property of both glycyrrhizic acid (GA)
and glabridin in reducing inﬂammation to accelerate wound regeneration on 3T3-L1 and
NIH-3T3 ﬁbroblast cell lines.
Methods: Cell proliferation andviability assay (MTTassay), scratchwoundhealing assays,
andquantitative real-timePCRwere conducted to investigate the effects on cell proliferation,
cell migration, and expression of CXC chemokine ligand 5 inﬂammation gene respectively.
Results: Results showed that at a low concentration of 1 × 10−8 mol/L, glabridin down
regulated cell proliferation in NIH-3T3 signiﬁcantly, suggesting its involvement in
ERK1/2 signaling pathway. GA and glabridin signiﬁcantly accelerated cell migration
through wound healing in both 3T3-L1 and NIH-3T3 and signiﬁcantly down regulated
the expression of CXC chemokine ligand 5 in 3T3-L1 at concentration 1 × 10−8 mol/L,
indicating the possible involvement of nuclear factor-kB and cyclooxygenase 2 tran-
scriptions modulation.
Conclusions: Both GA and glabridin can serve as potential treatment for chronic in-
ﬂammatory disease, and glabridin as an oncogenic inhibitor due to its anti-proliferative
property.1. Introduction
Wound healing is a complex biological event due to the
interplay of various tissue structures and many resident and
inﬁltrating cell types that serve as both inﬂammatory and
immunological effector cells. It consists of four phases: hemo-
stasis, inﬂammation (0–3 days), migration and proliferation (3–
12 days), and tissue remodeling (maturation) (3–6 months) that
inﬂuence the anabolic and catabolic reactions of tissue repair.
Profound study especially on chemokines which involved in the
speciﬁc trafﬁcking and recruitment of leukocytes during
inﬂammation phase is essential to illustrate the dynamic corre-
lation between inﬂammation, cell proliferation and migration [1].
Leukocyte subsets such as neutrophils which act as immu-
nological effector cells migrate immediately to the wound sur-
face to form a dense barrier against infecting pathogens, which
often associated intimately with the onset of acute inﬂammation.However, prolonged inﬂammation will lead to undesirable
pathogenesis [2]. Chemokines of the CXC family, particularly
CXC chemokine ligand 5 (CXCL5) has been reported as key
regulatory links between inﬂammation and angiogenesis
corresponding to CXC chemokine receptor 2 (CXCR2) [3,4].
Major efforts have focused in ﬁnding efﬁcient and novel
therapeutic agents. The use of antiseptics and antibiotics are
the current wound healing treatments that work in preventing
and ceasing of infection but do not directly involve in
supporting the wound healing process.
Prior study showed that liquorice (Glycyrrhiza glabra) was a
potent healing agent in open skin wounds in rabbits [5]. These
plant-derived compounds: glycyrrhizic acid (GA) and glabridin
from liquorice extract contain anti-oxidant and anti-
inﬂammatory properties that could be potential therapeutic
candidate to accelerate wound healing. It is hypothesized
that anti-inﬂammatory compounds could down regulateTaylor's University, No. 1 Jalan Taylor's, 47500,
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stry of Higher Education, Malaysia.
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wound closure. Present study aimed to evaluate the effects of
GA and glabridin on wound healing by accessing the cell pro-
liferation, cell migration and CXCL5 gene expression in 3T3-L1
and NIH-3T3 mouse ﬁbroblast cell lines.
2. Materials and methods
2.1. Cell culture and maintenance
NIH-3T3 mouse ﬁbroblast and 3T3-L1 pre-adipocyte cell
lines were adopted due to their angiogenesis nature. They were
cultured and maintained in Dulbecco's modiﬁed Eagle's medium
(DMEM; Sigma–Aldrich, USA) supplemented with 10% fetal
calf serum. Phosphate-buffered saline (PBS; Sigma–Aldrich,
USA) was used to rinse and wash the cells prior to trypsinization
with trypsin (Sigma–Aldrich, USA) to detach the cells during
sub-culturing, passaging and seeding.
2.2. Cell proliferation and viability assay (MTT assay)
Both NIH-3T3 and 3T3-L1 cell lines were harvested at 80%–
90% conﬂuence and seeded into 96 well plates at density
1.5 × 104 cells. Twenty-four hours post seeding, 150 mL of
culture medium was replaced with equal volume of GA and
glabridin respectively at concentrations ranging from
1 × 10−4 mol/L to 1 × 10−10 mol/L. After 24 h of incubation,
MTT solution (10 mL of 5 mg/mL MTT in sterile PBS) was
added and subsequently incubated for another 3.5 h. The su-
pernatant was decanted and 100 mL of dimethyl sulfoxide was
added to each well. The absorbance at 595 nm was measured
using a micro plate reader. The assay was carried out in tripli-
cates [6]. Results were analyzed statistically using statistical
software, IBM SPSS Statistics version 20 via independent t-
test with control: DMEM medium with 0.1% absolute ethanol.
Results were marked signiﬁcant at P < 0.05 and P < 0.01.
2.3. Scratch wound healing assay
NIH-3T3 and 3T3-L1 ﬁbroblast cell lines were seeded into 6
well plates at density of 2.0 × 105 cells. Pipette tip (size: 10–
200 mL) was used to create the wound after 24 h of cell seeding.
Each well was ﬁrst washed with sterile PBS and subsequently
2 mL per well of GA and glabridin were added separately into
each well with concentrations ranging from 1 × 10−5 mol/L to
1 × 10−9 mol/L with DMEMmedium with 0.1% absolute ethanol
as negative control. Images of wound closure were captured and
the measurement of each wound gap was taken at a treatment
interval of 6, 12 and 24 h in ﬁve replicates. The percentage of
wound closure was calculated based on the formula below [7]:
½ðInitial wound size at 0 treatment hour
− Specific interval of wound sizeÞ=Initial wound size× 100%Table 1
Characteristics of primers for total CXCL5 and GAPDH ampliﬁcation.
Primer Sequence (50->30)
Mouse CXCL5 forward primer TTCCTCAGTCATAGCCGCAA
Mouse CXCL5 reverse primer GGATCCAGACAGACCTCCTT
Mouse GAPDH forward primer GTTTCCTCGTCCCGTAGACA
Mouse GAPDH reverse primer CCTTGACTGTGCCGTTGAATResults obtained were analyzed statistically using statistical
software, IBM SPSS Statistics version 20 via independent t-test
and marked signiﬁcant at P < 0.05.
2.4. RT-qPCR quantiﬁcation of total CXCL5 gene
expression
2.4.1. Seeding and treatment of cell culture
Both NIH-3T3 and 3T3-L1 cell lines were seeded at density
of 1 × 106 into culture dishes. After 24 h of incubation, cells
were then washed with sterile PBS and treated with 3 mL vol-
ume of GA and glabridin at concentration that induced the best
migration rate. DMEM medium with 0.1% absolute ethanol was
added as control and treatments were done in triplicates.
2.4.2. Total mRNA extraction from cell lines
Total mRNA extraction for both control and treated cell lines
were done using FavorPrep™ Blood/Cultured Cell Total RNA
Mini Kit. The purity and quantity of total RNA extracted was
checked using Beckman Coulter NanoDrop Spectrophotometer
(USA) at wavelength 280 nm and 260 nm. The integrity of the
total RNA extracted was also being assessed by denaturation at
72 C for 10 min followed by visualization using 2% agarose gel
electrophoresis run at 80 V for approximately 40 min.
2.4.3. cDNA synthesis
The extracted RNA samples were incubated with RNase-Free
DNase (Promega RQ1 RNase-free DNase) reaction mixture at
37 C for 30 min. A volume of 1 mL of RQ1 DNase Stop So-
lution was added to stop the reaction followed by 10 min in-
cubation at 65 C. The treated total RNA was then used to
synthesize cDNA using qPCRBIO cDNA Synthesis Kit (PCR
Biosystems, United Kingdom). The RNA samples were incu-
bated at 42 C for 30 min followed by 85 C for 10 min to
denature the RTase.
2.4.4. Primer design for mouse total CXCL5 and
glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
gene
Gene speciﬁc forward and reverse primers were designed for
mouse total CXCL5 and GAPDH gene (Table 1) by Primer3
BioTools and cross-checked via National Centre for Biotech-
nology Information website using the standard nucleotide Basic
Local Alignment Searching Tool program.
Expression of the respective genes was quantiﬁed using the
optimized RT-qPCR parameters and protocols (Table 2) by
2 × qPCRBIO SyGreen Mix Lo-ROX (PCR Biosystems, United
Kingdom) in 10 mL reaction mixtures. All RT-qPCR and anal-
ysis were carried out on Eppendorf Mastercycler® ep realplex
PCR thermal cycler (Germany).
The comparison of mouse total CXCL5 expression between
control, GA-treated and glabridin-treated cell samples were per-
formed using the comparative CT (DDCT) method [8]. TheLength (bp) Tm (C) Amplicon size (bp)
20 56.3 168
C 21 56.6 168
20 56.4 200
20 55.7 200
Table 2
Optimized RT-qPCR thermal cycling protocols for mouse total CXCL5
and GAPDH ampliﬁcation.
Steps Temperature (C) Time Remarks
Polymerase activation 95 2 min
Denaturation 95 5 s 35 cycles
Annealing/Extension 57 25 s
Melt analysis
Test compound
0
-0.2
-0.4
-0.6
-0.8
-1
-1.2
-1.4
-1.6
-1.8
-2
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Figure 2. Relative expression for CXCL5 in NIH-3T3 cell line using
GAPDH as the endogenous reference, GA-treated and glabridin-treated
groups as targets and control group as calibrator.
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gel electrophoresis run at 80 V for approximately 40 min.
Statistical analysis for CXCL5 expression was performed using
the relative expression software tool MCS Beta 2006.
3. Results
3.1. Expression of mouse total CXCL5
Down regulation of mouse total CXCL5 inﬂammation gene
was observed in Figure 1 by GA and glabridin in 3T3-L1 with a
fold difference of −1.928 ± 0.128 (P < 0.01)
and −10.674 ± 0.025 (P < 0.01) respectively, and in NIH-3T3
(Figure 2) with a fold difference of −1.300 ± 0.146
and −1.623 ± 0.148 respectively. This down regulatory phe-
nomena by the anti-inﬂammation property of both GA and
glabridin could be due to involvement of nuclear factor-kB (NF-
kB) and cyclooxygenase 2 (COX-2) transcriptions modulation.
3.2. Scratch wound healing assay
3.2.1. Cell migration within time interval
Cell migration was observed and recorded in the form of per-
centage of wound closure at interval of time. Figures 3 and 4 show
a series compilation of wound healing progression of control, GA-
treated and glabridin-treated 3T3-L1 andNIH-3T3 cell lines at theTest compound
GA-treated 3T3-L1 Glabridin-treated 3T3-L1
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Figure 1. Relative expression for CXCL5 in 3T3-L1 cell line using
GAPDH as the endogenous reference, GA-treated and glabridin-treated
groups as targets and control group as calibrator.
**: P < 0.01.effective concentration (highest cell migration) respectively.
Completewound closure was observed at 24 h for controls of 3T3-
L1 cell line and at 42 h for controls of NIH-3T3 cell line.Control                              GA (1 × 10-8 mol/L)          Glabridin (1 × 10-8 mol/L)
0 h
6 h
18 h
24 h
Figure 3. Wound closure images (10× magniﬁcation) of GA-treated and
glabridin-treated 3T3-L1 cell line at effective concentration in comparison
with control.
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Figure 4. Wound closure images (10× magniﬁcation) of GA-treated and
glabridin-treated NIH-3T3 cell line at effective concentration in comparison
with control.
67.14
79.61 80.09 85.62 85.09
93.30 94.41 89.02 87.84 94.58
100.00100.00
Control             1 × 10-5           1 × 10-6            1 × 10-7           1 × 10-8           1 × 10-9
GA-treated 3T3-L1 Glabridin-treated 3T3-L1
Concentration (mol/L)
120.00
100.00
80.00
60.00
40.00
20.00
0.00
M
ea
n 
pe
rc
en
ta
ge
 o
f w
o
u
n
d 
cl
os
ur
e 
(%
)
*
*
*
*
** **
Figure 5. Comparison of mean percentage of wound closure against
different concentrations of GA and glabridin on 3T3-L1 cell line at 18 h.
*: P < 0.05; **: P < 0.01.
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Figure 6. Comparison of mean percentage of wound closure against
different concentrations of GA and glabridin on NIH-3T3 cell line at 24 h.
*: P < 0.05.
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compounds
Both GA and glabridin stimulated effective cell migration at
lower concentration of 1 × 10−8 mol/L. Complete wound closure
of (100.00 ± 0.00)% (P < 0.01) was observed in 3T3-L1 treated
with GA and glabridin at 18 h respectively (Figures 3 and 5),
whereas in NIH-3T3, wound closure of (93.90 ± 3.53)%
(P < 0.05) and (90.46 ± 5.05)% (P < 0.05), were observed at
24 h for GA-treated and at 18 h for glabridin-treated NIH-3T3
respectively (Figures 4 and 6).100.00100.00 110.95
142.46
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Figure 7. Comparison of mean percentage of cell proliferation against differe
*: P < 0.05.3.3. MTT assay
Both GA and glabridin exhibited a similar trend in 3T3-L1 cell
line in which, both increased cell proliferation in higher drug
concentrations and decreased cell proliferation at lower drug
concentrations (Figure 7). However, conﬂicting effects were
exhibited by GA and glabridin on cell proliferation in NIH-3T3
cell line. Lower concentration, speciﬁcally concentration
1 × 10−8 mol/L, which was also the effective concentration for
increased cell migration and decreased inﬂammation, of glabridin
showed down regulation of cell proliferation onNIH-3T3 cell lines
with mean percentage of (84.10 ± 5.63)%, compared to highestidin-treated 3T3-L1
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Figure 8. Comparison of mean percentage of cell proliferation against different concentrations of GA and glabridin on NIH-3T3 cell line respectively.
*: P < 0.05; **: P < 0.01.
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with mean percentage of (114.95 ± 5.63)% (Figure 8).
4. Discussion
4.1. Expression of total CXCL5 inﬂammation gene
4.1.1. Down-regulation of NF-kB inﬂammation pathway
by inhibition of reactive oxygen species generation by
neutrophils
CXCL5 is produced upon stimulation of cells with inﬂam-
matory cytokines. According to Akamatsu et al., the proposed
anti-inﬂammatory action of GA is by inhibiting the generation of
reactive oxygen species by neutrophils, the most potent in-
ﬂammatory mediator at the site of inﬂammation [9]. Yokota et al.
indicated that the anti-inﬂammatory action of glabridin was by
its two hydroxyl groups that inhibit superoxide anion pro-
ductions and cyclooxygenase activities [10]. Therefore, it can be
postulated that both GA and glabridin down regulate the NF-kB
transcription factor via inhibition of oxidative stimulus, which
down regulates the activation of IkB kinase, an enzyme
complex that is involved in the upstream NF-kB signal
transduction cascade that propagates the cellular response to
inﬂammation. When inﬂammatory cytokines are down
regulated, production of CXCL5 is also down regulated.
4.1.2. Down-regulation of COX-2 inﬂammation pathway
The down-regulatory effect observed can also be explained
via the mechanism of COX-2 inﬂammation pathway. The down
regulation of NF-kB transcription factor further down regulates
COX-2 expression, which is of similar mechanism to non-
steroidal anti-inﬂammatory drugs (NSAIDs) that are widely
used for the treatment of pain, fever, and inﬂammation. NSAIDs
act via inhibition of COX-2 enzyme at the site of inﬂammation,
which catalyzes the conversion of arachidonic acid to prosta-
glandins. However, NSAIDs therapy produces harmful side ef-
fects such as gastric toxicity due to non-regulated inhibition of
COX-1 [11]. Therefore, the sensitivity and speciﬁcity of anti-
inﬂammatory action for both GA and glabridin should be
further explored.4.2. GA and glabridin induced higher cell migration in
both 3T3-L1 and NIH-3T3 cell line
The stimulated cell migration effect could be one of the
response by the down regulation of inﬂammation during wound
healing. The effect can be further supported by the study done
by Dong et al., [12]. Down regulation of CXCL5 inﬂammation
gene down regulates the activation of CXCR2 receptor, which
further down regulates the activation of epidermal growth
factor receptor that is responsible for the activation of PI3K/
Akt pathway, followed by NF-kB and COX-2 pathway, which
resulted in down regulation of key inﬂammatory regulator in
chronic infections, prostaglandins E2. Hence, it can be suggested
that down regulation of inﬂammatory phase accelerates the
healing process to the third phase, cell migration to allow faster
wound regeneration. However, the exact mechanism is yet to be
determined due to the involvement of various growth factors and
wound healing phases.
4.3. GA and glabridin regulated cell proliferation in
both 3T3-L1 and NIH-3T3 cell line
The mitogen-activated protein kinase family constitutes of
extracellular signal-regulated kinase, stress-activated protein
kinases, and Jun amino-terminal kinases, all of which can be
activated by upstream regulators for example Ras and Raf-1, that
phosphorylate downstream proteins in the respective cascades to
regulate expression of various genes corresponding to cell pro-
liferation and inﬂammation [13]. Results were in agreement with
the study conducted by Zhou et al., which showed that the down
regulation of CXCL5 inﬂammation gene which corresponds to
CXCR2 chemokine receptor, down regulates phosphorylation
of extracellular signal-regulated kinase pathway that mediates
cell proliferation [14]. Thus, a decrease in inﬂammation will
subsequently reduce cell proliferation as activation of both
inﬂammation pathway, PI3K/Akt and cell proliferation
pathway, extracellular signal-regulated kinases are modulated
by chemokines for example CXCL5. Both GA and glabridin
interfere with cell proliferation and inﬂammation via similar
pathways. However, glabridin exhibited better down regulatory
Hong Yung Yip et al./Asian Pac J Trop Biomed 2016; 6(2): 108–113 113effect on inﬂammation compared to GA in both 3T3-L1 and
NIH-3T3 cell lines. This could be due to glabridin interfering
directly on COX-2, compared to GA that acts upon the upstream
NF-kB protein complex.
In conclusion, both GA and glabridin exhibited promising
potential in wound healing. Future work should explore on other
beneﬁcial properties of both GA and glabridin and transform
them into regenerative cell therapy for treating chronic in-
ﬂammations. The anti-proliferative property of glabridin can be
proposed as a chemotherapeutic agent for treating cancer asso-
ciated ﬁbroblasts.Conﬂict of interest statement
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